SCHEMBL30890797

SCHEMBL30890797

CN(C(=O)O)C(C=O)CC1CC1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.39
ENPEP Q07075 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9102349 0.77 ANPEP (0.33) ANPEPENPEP
SCHEMBL8258507 0.74 CTSL (0.30)
SCHEMBL4971460 0.73
SCHEMBL15332671 0.72
SCHEMBL9103897 0.71 CTSK (0.33)
SCHEMBL14966957 0.71 CHRM1 (0.38)
SCHEMBL1424364 0.71 CTSK (0.40)
SCHEMBL1867665 0.70 CTSK (0.38)
SCHEMBL6245315 0.70 CTSK (0.38)
SCHEMBL6673351 0.69 GRIK1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 WO disclosed